Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A MedlinePlus Genetics resource link for melanoma appears among the study’s related health-information links.
    Difference
    0.2%
    Check dated 2026-11-17T05:30:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The study record for PV-10 combined with pembrolizumab in metastatic melanoma is available, including its phase 1b/2 design, eligibility criteria, treatment arms, outcomes, and five U.S. locations.
    Difference
    51%
    Check dated 2026-11-10T06:54:14.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T06:21:07.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH website transition and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-27T06:45:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site revision label on the 403 Forbidden page changed from v3.7.1 to v3.7.2; the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-20T08:21:35.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-13T08:17:57.000Z thumbnail image

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.